Is atherosclerosis accelerated by CAPD?

Area of Science:

• Nephrology
• Cardiology
• Internal Medicine

Background:

• Cardiovascular complications are common in patients undergoing renal replacement therapy.
• The impact of peritoneal dialysis (PD) on atherosclerosis progression remains unclear.
• Continuous ambulatory peritoneal dialysis (CAPD) may influence lipid profiles, but long-term effects are debated.

Purpose of the Study:

• To assess whether CAPD itself alters lipid profiles in the long term.
• To investigate the relationship between CAPD, lipid profiles, and atherosclerosis.
• To identify potential risk factors for accelerated atherosclerosis in CAPD patients.

Main Methods:

• Measured conventional lipid profiles (T.chol., triglyceride, HDL, LDL, apo B/A-I) in 16 stable CAPD patients over 30 months.
• Excluded diabetic end-stage renal disease (DMESRD) patients.
• Assessed Lp(a) levels, vascular accidents, aortic calcification, treadmill tests, aortic pulse wave velocity (AoPWV), and abdominal aortic calcification severity.

Main Results:

• Conventional lipid profiles and apo B/A-I showed no significant long-term changes with CAPD.
• Higher Lp(a) levels (> 31 mg/dL) were associated with a significantly higher incidence of vascular accidents (p < 0.05).
• Increased AoPWV and more severe aortic calcification correlated with longer CAPD duration, independent of lipid profiles.

Conclusions:

• CAPD, under strict sampling conditions, does not appear to significantly alter lipid profiles.
• Elevated Lp(a) is a risk factor for cardiovascular events in CAPD patients.
• Long-term CAPD may accelerate atherosclerosis via mechanisms other than lipid abnormalities, possibly involving calcium metabolism.